Axon Enterprise (NASDAQ:AXON) Given Outperform Rating at William Blair

Axon Enterprise (NASDAQ:AXON - Get Free Report)'s stock had its "outperform" rating reaffirmed by research analysts at William Blair in a research report issued to clients and investors on Wednesday, RTT News reports.

A number of other research firms have also weighed in on AXON. JMP Securities raised their target price on shares of Axon Enterprise from $250.00 to $285.00 and gave the company a "market outperform" rating in a report on Tuesday, February 6th. Needham & Company LLC reissued a "buy" rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Wednesday. Argus started coverage on shares of Axon Enterprise in a research note on Wednesday, March 13th. They set a "buy" rating and a $380.00 price objective for the company. Barclays lifted their price objective on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an "overweight" rating in a research note on Thursday, February 29th. Finally, Morgan Stanley lifted their price objective on shares of Axon Enterprise from $250.00 to $285.00 and gave the stock an "equal weight" rating in a research note on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $312.64.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded up $0.85 during trading on Wednesday, hitting $302.41. The company's stock had a trading volume of 524,730 shares, compared to its average volume of 471,655. The company has a 50-day moving average of $302.15 and a 200-day moving average of $260.29. Axon Enterprise has a 12 month low of $175.37 and a 12 month high of $329.87. The company has a debt-to-equity ratio of 0.42, a current ratio of 3.00 and a quick ratio of 2.66. The firm has a market cap of $22.82 billion, a price-to-earnings ratio of 131.54 and a beta of 0.93.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The company had revenue of $432.14 million for the quarter, compared to analysts' expectations of $418.97 million. On average, sell-side analysts expect that Axon Enterprise will post 2.44 earnings per share for the current year.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. ICA Group Wealth Management LLC purchased a new position in Axon Enterprise in the fourth quarter valued at about $26,000. Trivant Custom Portfolio Group LLC purchased a new stake in shares of Axon Enterprise during the first quarter worth about $31,000. First PREMIER Bank purchased a new stake in shares of Axon Enterprise during the first quarter worth about $33,000. BKM Wealth Management LLC purchased a new stake in shares of Axon Enterprise during the fourth quarter worth about $32,000. Finally, Rise Advisors LLC grew its stake in shares of Axon Enterprise by 49.0% during the first quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company's stock worth $45,000 after acquiring an additional 47 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.